NCT05994963View on ClinicalTrials.gov

A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.

PHASE1CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

February 26, 2024

Study Completion Date

February 26, 2024

Conditions

Healthy

Interventions

DRUG

sisunatovir

Administered as either capsules in fasted state or tablet in fasted or fed state.

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit - Brussels, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT05994963 - A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants. | Biotech Hunter | Biotech Hunter